Companies›Consumer Discretionary›Consumer Services›Retailing
NSE:MEDPLUS

MEDPLUS HEALTH SERV LTD

Consumer Services › Retailing·NIFTY MICROCAP 250NIFTY SMALLCAP 500NIFTY TOTAL MARKET
₹626.00
at close · 27 Oct 2026
▲ 11.00 (+1.79%)

Latest filings

  1. Q2 FY27 revenue rises 21.3% as operating margin improves sequentially · Investor Communications
  2. MedPlus allots 19,095 shares on employee stock option exercise · Capital Market Events
  3. Sales up 21% in September quarter, but profit is nearly flat · Board & Shareholder Meetings
All filings ↓
Ask Nexa about MEDPLUS HEALTH SERV LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates a chain of pharmacy retail stores across India selling pharmaceutical and non-pharmaceutical products, with a smaller diagnostic services arm. In FY26, the retail pharmacy segment contributed 98.1% of segment revenue at Rs 6,760.1 crore, while diagnostic services added 1.9% at Rs 131 crore. The store network reached 5,476 stores covering 2.9 million sq ft as of Q1 FY27, spanning 14 states and supported by 27,686 employees. The business added 146 net stores in Q1 FY27 (131 of them under a franchisee model) and has guided to 800 net additions for FY27. In Q1 FY27, pharmacy revenue grew 21.8% year-on-year; mature stores older than 12 months delivered a 10.4% store-level EBITDA margin. Private-label products made up 20% of pharmacy revenue (10.7% pharma plus 9.3% non-pharma), with a subscription base of 44-45 lakh members paying a Rs 149 fee. Subsidiary Optival Health Solutions runs roughly 90% of operations. Employee costs are the largest cost line at 12.8% of revenue, with depreciation at 4.1% and other operating expenses at 4.6%.

Revenue mix · reported segments
Retail98.1%
Diagnostic services1.9%
Others0.0%
Operating scale
Store network
5,476 storesQ1 FY27
Retail floor area
2.9 million sq ftQ1 FY27
States of operation
14 statesFY26
Net store additions (Q1 FY27)
146 (of which 131 franchisee)Q1 FY27
FY27 net store guidance
800 net additionsFY27
Private-label subscription base
44-45 lakh members at Rs 149Q1 FY27
Who pays it
Indian retail consumers buying prescription and OTC medicines, wellness products, and in-store diagnostic services
Biggest cost
Employee cost at 12.8% of revenue, reflecting the labour-intensive nature of running a large pharmacy store network
Kind of business
Labour-intensive, scale-driven pharmacy retail with an asset-light franchisee model and a small diagnostic services adjunct
Where it sits
Operates 5,476 stores across 14 states under the MedPlus banner, with subsidiary Optival Health Solutions running roughly 90% of operations
Market Cap
₹7,520 Cr
P / E (TTM)
35.7×
EV / EBITDA
10.7×
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
9.1%·
ROCE (5y median)
ROE 6.7% (5y median) · margin 9.8%
Leverage
0.00·
Debt / Equity · low
Net cash ₹198 Cr
Revenue FY22→FY26
1.8×▲
Margin +0.7 pts
₹3,779 Cr → ₹6,892 Cr
Cash conversion
2.48×▲
Operating cash ÷ profit · 5 yrs
₹1,440 Cr on ₹580 Cr
Moves on a normal day
0.90%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 65 Retailing peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#36/52
P/B#29/50
ROCE#26/63
ROE#17/49
Debt / Equity#1/49
EBITDA margin#28/50
Revenue growth#21/51
Profit growth#38/46

Scorecard

Measured from the filed financials, judged against its Retailing peers · as of FY26 — not investment advice

Strengths
No borrowings on the balance sheet
lower than 69% of its 49 Retailing peers
Over 5 years it reported ₹580 Cr of profit and ₹1,440 Cr of operating cash — 2.48×
Profit is converting into cash
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

MEDPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from MEDPLUS HEALTH SERV LTD's filed financials and exchange disclosures

What does MEDPLUS HEALTH SERV LTD do?

MEDPLUS HEALTH SERV LTD is a Retailing company listed on NSE and BSE, trading under the symbol MEDPLUS.

Is MEDPLUS HEALTH SERV LTD profitable?

Yes. Over the trailing twelve months MEDPLUS HEALTH SERV LTD reported a net profit of ₹210 Cr on revenue of ₹7,229 Cr.

Does MEDPLUS HEALTH SERV LTD pay a dividend?

Not in the latest reported year — MEDPLUS HEALTH SERV LTD's dividend payout for FY26 was nil.

Is MEDPLUS HEALTH SERV LTD debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹198 Cr of cash.

Is MEDPLUS HEALTH SERV LTD expensive compared with its peers?

On trailing P/E, MEDPLUS HEALTH SERV LTD ranks 36 of 52 in Retailing — cheaper than 31% of them, against an industry median of 23.2×. This is a position, not a valuation judgement.

How much does the MEDPLUS HEALTH SERV LTD share price move in a day?

On a typical session MEDPLUS HEALTH SERV LTD moves 0.90% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

Where can I track MEDPLUS HEALTH SERV LTD's announcements?

Every NSE and BSE filing by MEDPLUS HEALTH SERV LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.